|Magnetic resonance neurography to study peripheral neuropathies
|Brito V, Ciapponi A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, López A, Rey-Ares L
This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Brito V, Ciapponi A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, López A, Rey-Ares L. Magnetic resonance neurography to study peripheral neuropathies. Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Informe de Respuesta Rapida No. 497. 2016
There is no evidence having shown clinical benefits with the inclusion of magnetic resonance neurography as a diagnostic tool in neuropathies, plexopathies and polyneuropathies of different etiologies.
Very low-quality evidence shows that magnetic resonance neurography might contribute to identifying certain structural abnormalities in the peripheral nerves.
The clinical practice guidelines identified point out magnetic resonance neurography as an imaging technology still at investigational stage; which so far has not proved to be better than the standard diagnostic tests to study neuropathies.
Most coverage policies identified from foreign sponsors do not cover magnetic resonance neurography because they consider it at experimental stage.
In Argentina, magnetic resonance neurography is not included in the Mandatory Medical Program.
Final publication URL
Subject indexing assigned by CRD
Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Peripheral Nervous System Diseases
Country of organisation
An English language summary is available.
Address for correspondence
Institute for Clinical Effectiveness and Health Policy, Viamonte 2146 - 3 Piso, C1056ABH Ciudad de Buenos Aires, Argentina Tel: +54 11 49 66 00 82 Fax:+54 11 49 53 40 58 Email: email@example.com
Date abstract record published